Yali Liu
- Cancer Research top 5%
- Molecular Biology top 5%
- Natural product bioactivities and synthesis 10
- Ubiquitin and proteasome pathways 6
- Bone Metabolism and Diseases 5
- Metabolomics and Mass Spectrometry Studies 4
- RNA and protein synthesis mechanisms 4
- RNA modifications and cancer 4
- Pharmacology top 5%
- Genetics top 10%
-
- Phytochemistry and Biological Activities 6
-
- Cancer-related Molecular Pathways 4
- Co-authors
- Abid NaeemPengyi HuJing ZhangMing YangQin ZhengWeifeng ZhuYonggui SongDan Su
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yali Liu
89 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Cancer Research 488
- Molecular Biology 1.5k
- Pharmacology 137
- Genetics 152
- Complementary and alternative medicine 112
Countries citing papers authored by Yali Liu
This map shows the geographic impact of Yali Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali Liu more than expected).
Fields of papers citing papers by Yali Liu
This network shows the impact of papers produced by Yali Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali Liu. The network helps show where Yali Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yali Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 4 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 33 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 26 | |
| 7 | 2023 | 20 | |
| 8 | 2023 | 20 | |
| 9 | 2023 | 5 | |
| 10 | 2022 | 97 | |
| 11 | 2022 | 14 | |
| 12 | 2021 | 23 | |
| 13 | 2020 | 29 | |
| 14 | 2017 | 7 | |
| 15 | 2016 | 35 | |
| 16 | 2016 | 5 | |
| 17 | 2015 | 22 | |
| 18 | Preparation of 99Tcm labeled survivin mRNA antisense PNA and gene imaging in nude mice bearing lung carcinoma A549 xenografts | 2011 | 2 |
| 19 | 2011 | 75 | |
| 20 | Inhibitory effect of Rab23 on growth and proliferation of breast cancer cells. | 2009 | 2 |
About Yali Liu
Yali Liu is a scholar working on Molecular Biology, Biological Psychiatry and Pharmacology, having authored 90 papers that have together received 2.3k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (10 papers), Ubiquitin and proteasome pathways (6 papers), Phytochemistry and Biological Activities (6 papers), Bone Metabolism and Diseases (5 papers), Metabolomics and Mass Spectrometry Studies (4 papers), Cancer-related Molecular Pathways (4 papers), RNA and protein synthesis mechanisms (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (488 citations), Molecular Biology (1.5k citations) and Pharmacology (137 citations). Yali Liu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Abid Naeem, Pengyi Hu, Jing Zhang, Ming Yang, Qin Zheng, Weifeng Zhu, Yonggui Song, Dan Su, Liang Tang and Yan Jin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.